Host Dr. Alan Brown continues his series of conversations demystifying familial hypercholesterolemia (FH), this week with Dr. Paul Hopkins, co-director of cardiovascular genetics and director of the Cardiovascular Disease Prevention Clinic at the University of Utah. They define FH from a genetics perspective, and discuss genetic causes, prevalence, populations with higher prevalence, and screening guidelines.
Diagnosis, Prevalence, and Screening of Familial Hypercholesterolemia

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Host Dr. Alan Brown continues his series of conversations demystifying familial hypercholesterolemia (FH), this week with Dr. Paul Hopkins, co-director of cardiovascular genetics and director of the Cardiovascular Disease Prevention Clinic at the University of Utah. They define FH from a genetics perspective, and discuss genetic causes, prevalence, populations with higher prevalence, and screening guidelines.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Digital Therapeutics Clinical Trials: From Design to Data Interpretation
Engaging Patients and Caregivers About Digital Therapeutics
FCS and SHTG: Are We Meeting the Need?
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?